Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer ; volume:14 ; number:1 ; day:7 ; month:7 ; year:2016 ; pages:1-8 ; date:12.2016
Journal of translational medicine ; 14, Heft 1 (7.7.2016), 1-8, 12.2016
- Urheber
-
Murugan, Avaniyapuram Kannan
- Beteiligte Personen und Organisationen
-
Qasem, Ebtesam
Al-Hindi, Hindi
Shi, Yufei
Alzahrani, Ali S.
SpringerLink (Online service)
- DOI
-
10.1186/s12967-016-0958-x
- URN
-
urn:nbn:de:1111-201607102913
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Murugan, Avaniyapuram Kannan
- Qasem, Ebtesam
- Al-Hindi, Hindi
- Shi, Yufei
- Alzahrani, Ali S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation